Author:
Yang Ying,Li Zhiheng,Yang Yang,Xiao Peifang,He Zhixu,Zhang Zimu,Li Yizhen,Shi Lei,Wang Xiaodong,Tao Yanfang,Fan Junjie,Ji Tongting,Zhang Fenli,Zhang Yongping,Zhou Bi,Yu Juanjuan,Guo Ailian,Jiao Wanyan,Wu Yumeng,Wei Zhongling,Li Yan,Wu Di,Wu Yijun,Gao Li,Hu Yixin,pan jian,Hu Shaoyan,Yang Xiaoyan
Reference57 articles.
1. Acute megakaryocytic leukemia: What have we learned;A W Hahn;Blood Rev,2016
2. Definition of a standard-risk group in children with AML;U Creutzig;Br J Haematol,1999
3. The biology of pediatric acute megakaryoblastic leukemia;T A Gruber;Blood,2015
4. Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development;J Li;Front Cell Dev Biol,2023
5. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience;U H Athale;Blood,2001